Three competitors are not enough.
We don't want MCI to have control of the Internet infrastructure.
This new layer turns every distributor into yet another owner.
Getting control and ownership -- some call it god power -- over the Internet through the power to tax. We're supposed to feel comfortable because the current interim board members are nice people.
Roche has had plenty of time to figure out what its options are regarding the licensing of the patents. There are too many potential suppliers to undertake individual negotiations with each company. Roche needs to simply identify the relevant terms it will impose on generic suppliers and offer open licenses to anyone who can comply.
It's not the last time we are going to be in this situation. It's been twice in four years.
It's no big stretch to do it for a medicine, particularly in a case like this, where a patent owner cannot supply the stockpiles of medicines that the WHO says are necessary.